TrialStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2026
Stereotactic heart ablative radiotherapy (SHARP): a prospective multicentric phase II trial.
Aurélie Gaasch et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.